Market Fit Inflexxion specializes in substance use, behavioral health, pain management, opioid risk management, and healthcare data analysis for hospitals, provider communities, pharmaceutical companies, and regulatory authorities, indicating multiple cross-sell opportunities across payers, providers, and life sciences.

Data Capabilities Their unique point-of-care data collection combined with internet monitoring and web surveys enables comprehensive surveillance, risk assessment, and outcome measurement, presenting upsell potential for advanced analytics, dashboards, and regulatory reporting solutions.

Acquisition Momentum History of acquisition by Integrated Behavioral Health and a product evolution with PainCAS 3.0 suggests resilience and integration potential with larger behavioral health platforms, opening doors for partnerships or channel sales with IBH network.

Revenue Range Current revenue range of 10–25 million and a lean team (11–50 employees) signals a mid-market footprint ripe for scalable solutions, managed services, or deployment of modular analytics suites to expand wallet share without large enterprise scale.

Growth Path Experienced leadership changes and long-standing focus since 1989, with potential to expand into broader healthcare data intelligence, risk management for opioid use, and patient-provider education content, offering strategic upsell to pharma, regulatory bodies, and health systems.